Peptides 101 — What They Are and Why They're Everywhere
A peptide is a short chain of amino acids — basically a tiny protein fragment. Your body produces hundreds of natural peptides that act as signaling molecules: they tell specific cells to DO specific things. Insulin is a peptide. GLP-1 is a peptide. Growth hormone releasing hormone is a peptide. Your body runs on peptide signals.
Therapeutic peptides are synthetic or bioidentical versions of these natural signaling molecules. When you inject semaglutide, you're injecting a peptide that mimics the GLP-1 signal your gut naturally produces after eating. When you use a growth hormone secretagogue like CJC-1295, you're injecting a peptide that signals your pituitary gland to release more growth hormone. The concept is the same: send a signal, trigger a response.
Peptides have exploded in popularity because they're targeted. Unlike broad-spectrum medications that affect multiple systems, peptides typically activate specific receptor pathways. That precision makes them attractive for people who want specific outcomes — fat loss, muscle preservation, recovery, sleep, cognitive enhancement — without the systemic side effects of broader interventions.
But popularity has also created confusion. Not all peptides marketed for weight loss actually produce meaningful weight loss. And the quality, sourcing, and supervision landscape ranges from pharmaceutical-grade clinical programs to unregulated gray-market powders. Understanding the differences is critical.
"I was buying research peptides online for months before I came to Pause & Reset. Same peptides, but now with actual lab monitoring and hormonal support — the results are incomparable."
— Age 47
The Three Categories of Weight Loss Peptides — Ranked by Evidence
CATEGORY 1: GLP-1 RECEPTOR AGONISTS (Strong Evidence). This is where the serious weight loss lives. Semaglutide (Wegovy/Ozempic), tirzepatide (Mounjaro/Zepbound), and the upcoming retatrutide are all peptides that activate GLP-1 receptors in the brain and gut. They reduce appetite, slow gastric emptying, and improve insulin sensitivity. Average weight loss: 15-28% of body weight depending on the specific peptide. These are FDA-approved (semaglutide and tirzepatide), extensively studied, and available through prescription and compounding pharmacies. This is not experimental — this is the most evidence-backed weight loss intervention available today.
CATEGORY 2: GROWTH HORMONE SECRETAGOGUES (Moderate Evidence). Peptides like CJC-1295, ipamorelin, sermorelin, and tesamorelin stimulate your pituitary gland to produce more growth hormone. Growth hormone supports fat metabolism (particularly visceral fat), muscle preservation, recovery, skin quality, and sleep. These peptides don't produce the dramatic weight loss numbers of GLP-1 agonists, but they support body COMPOSITION — less fat, more muscle — which is arguably more important than the number on the scale. They're especially relevant for women over 40 whose growth hormone production has naturally declined.
CATEGORY 3: FAT-BURNING AND METABOLIC PEPTIDES (Emerging/Limited Evidence). This includes peptides like AOD-9604 (a growth hormone fragment marketed for fat loss), MOTS-c (a mitochondrial-derived peptide linked to metabolic regulation), and 5-amino-1MQ (an enzyme inhibitor that may promote fat cell metabolism). The evidence for these is much thinner — mostly preclinical studies, small trials, or mechanistic research without large-scale human data. Some show promise. But the gap between 'interesting mechanism' and 'proven in humans at meaningful scale' is significant. Be cautious with claims made about these peptides — the marketing often outpaces the science.
Which Peptides Actually Matter for Women in the Hormonal Transition
For women in perimenopause and menopause, the peptide conversation needs to be filtered through a hormonal lens. Here's how each category applies specifically to you:
GLP-1 AGONISTS + HORMONAL OPTIMIZATION. This is the most powerful combination available. GLP-1 peptides address appetite, insulin resistance, and metabolic rate — all of which are disrupted during menopause. Hormonal optimization (estrogen, progesterone, testosterone) addresses the upstream CAUSE of the metabolic disruption. Together, the GLP-1 peptide is working inside a metabolic environment that's been restored to respond properly. We cover this extensively in our GLP-1 weight loss treatment page.
GROWTH HORMONE SECRETAGOGUES + MENOPAUSE. Growth hormone naturally declines with age — and the decline accelerates during menopause. For women experiencing muscle loss, slow recovery, poor sleep, skin thinning, and stubborn visceral fat, growth hormone peptides like sermorelin or CJC-1295/ipamorelin can provide meaningful body composition support. They're particularly interesting when combined with testosterone (which also supports muscle) and strength training. The evidence here is moderate but clinically relevant.
PT-141 (BREMELANOTIDE). This deserves a special mention. PT-141 is a peptide that activates melanocortin receptors in the brain to stimulate sexual desire. It's actually FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women. For perimenopausal and menopausal women experiencing desire loss — which is primarily driven by testosterone and estrogen decline — PT-141 can provide an additional tool alongside hormonal support. It works on the brain's desire pathway directly, which is different from the tissue-level support that estrogen provides.
BPC-157. Body Protection Compound-157 is a gut-derived peptide that promotes tissue repair, gut healing, and anti-inflammatory effects. While not a weight loss peptide per se, BPC-157 is widely used in functional medicine for women with gut issues, joint pain, and tissue recovery — all of which are common during menopause. The evidence is primarily preclinical, but clinical use is widespread and safety reports are generally favorable.
Let's Talk About Where You're Getting These — Because It Matters
This is the part nobody in the peptide community wants to talk about honestly. So we will.
Pharmaceutical-grade peptides (FDA-approved medications like semaglutide, tirzepatide, or Vyleesi) undergo rigorous manufacturing, testing, and quality control. You know what's in the vial. You know the dose. You know the purity. These are the gold standard.
Compounded peptides from licensed compounding pharmacies are the next tier. These pharmacies are regulated, inspected, and required to meet purity and potency standards. Compounded semaglutide, for example, is widely used and generally reliable. But compounding pharmacy quality is NOT uniform — some are excellent, some are marginal. The pharmacy your provider uses matters.
Research peptides from online vendors are the wild west. Some vendors produce high-quality, independently tested peptides. Others sell underdosed, impure, or mislabeled products. There is no FDA oversight. There is no standardized quality testing. 'Certificate of Analysis' documents can be fabricated. You are trusting the vendor entirely — and the consequences of injecting impure peptides are real.
We're not going to pretend research peptides don't exist or that people don't use them. They do. If you're going that route, third-party testing (HPLC and mass spectrometry) is the minimum standard you should demand. And medical supervision — including lab monitoring of your metabolic markers — is strongly recommended regardless of where your peptides come from.
At Pause & Reset, we work with licensed compounding pharmacies that meet strict quality standards. We know what's in the vial because we verify it. And we monitor your response with lab work — not just subjective feedback — to make sure what you're taking is doing what it should.
How We Use Peptides at Pause & Reset
Peptides are tools in a toolkit — not the toolkit itself. We prescribe and supervise peptide therapy as part of comprehensive protocols, not as standalone interventions. The order is always: evaluate fully, address hormonal foundation, optimize metabolic health, THEN add targeted peptide support where specific gaps remain.
For weight loss specifically: GLP-1 agonists (semaglutide or tirzepatide) combined with hormonal optimization are our primary approach. We select the medication based on your metabolic profile, not the latest trend. Growth hormone peptides may be added for women who need additional body composition support — particularly muscle preservation during weight loss, which is critical for women over 40.
For sexual health: PT-141 alongside testosterone and estrogen optimization provides the most complete approach to desire loss during menopause — addressing both the brain pathway and the hormonal foundation.
For recovery and gut health: BPC-157 and targeted peptides may be recommended for women with persistent gut issues, joint pain, or slow tissue recovery that hasn't fully resolved with hormonal and nutritional support.
Every peptide recommendation starts with data — your labs, your symptoms, your response to foundational treatment, and your specific goals. We don't prescribe peptides because they're trendy. We prescribe them because your clinical picture indicates they'll help.